Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome
Objective: Extreme obesity is a core phenotypic feature of Prader-Willi syndrome (PWS). Among numerous metabolic regulators, the endocannabinoid (eCB) system is critically involved in controlling feeding, body weight, and energy metabolism, and a globally acting cannabinoid-1 receptor (CB1R) blockad...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , , , , , , , |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Elsevier,
2016-12-01T00:00:00Z.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
Connect to this object online.3rd Floor Main Library
Plaatsingsnummer: |
A1234.567 |
---|---|
Kopie 1 | Beschikbaar |